Ajanta Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajanta Pharma has informed the stock exchanges that its trading window for dealing in company securities will remain closed from Tuesday, 1st July 2025, until 48 hours after the declaration of its financial results for the quarter ended 30th June 2025. This closure is in line with SEBI's Prohibition of Insider Trading Regulations, 2015 and the company's internal code of conduct for insiders. The communication was signed by Gaurang Shah, Sr. VP – Legal & Company Secretary. This is a routine compliance step taken by listed companies before announcing quarterly results to prevent insider trading.
This is a standard regulatory compliance filing and does not directly impact shareholders. However, it signals that the company is preparing to announce its Q1 FY26 results in the coming weeks, which could be a key catalyst for the stock.